Skip to main content
. 2018 Feb 25;2018(2):CD004982. doi: 10.1002/14651858.CD004982.pub6

7.1. Analysis.

7.1

Comparison 7 Thirty‐day intermediate low molecular weight heparin (LMWH) versus 10‐day intermediate LMWH, Outcome 1 Venous thromboembolism end‐of‐treatment.